Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome

Simon P. Dunlop(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Robert E. Spiller(Nottingham University Hospitals NHS Trust), Alan C. Perkins(NIHR Nottingham Digestive Diseases Biomedical Research Unit), Nicholas Coleman(University Hospital Southampton NHS Foundation Trust), Elaine Blackshaw, C.A. Marsden(Queen's Medical Centre), Gulzar Singh

Clinical Gastroenterology and Hepatology

April 1, 2005

10.1016/s1542-3565(04)00726-8

Cited by 358

Related Papers

Functional Bowel Disorders

|Gastroenterology|2006|4.8k

Bowel Disorders

|Gastroenterology|2016|2.8k

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute <i>Campylobacter</i> enteritis and in post-dysenteric irritable bowel syndrome

|Gut|2000|1.2k

Postinfectious Irritable Bowel Syndrome

|Gastroenterology|2009|1k

Irritable bowel syndrome

|Nature Reviews Disease Primers|2016|981